DK1102747T3 - Krystalformer af osenetant - Google Patents

Krystalformer af osenetant

Info

Publication number
DK1102747T3
DK1102747T3 DK99936672T DK99936672T DK1102747T3 DK 1102747 T3 DK1102747 T3 DK 1102747T3 DK 99936672 T DK99936672 T DK 99936672T DK 99936672 T DK99936672 T DK 99936672T DK 1102747 T3 DK1102747 T3 DK 1102747T3
Authority
DK
Denmark
Prior art keywords
osenetant
crystal forms
crystal
forms
Prior art date
Application number
DK99936672T
Other languages
English (en)
Inventor
Alain Alcade
Gilles Anne-Archard
Patrick Grosclaude
Olivier Monnier
Jerome Roche
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of DK1102747T3 publication Critical patent/DK1102747T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK99936672T 1998-08-05 1999-08-03 Krystalformer af osenetant DK1102747T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9810107A FR2782082B3 (fr) 1998-08-05 1998-08-05 Formes cristallines de (r)-(+)-n-[[3-[1-benzoyl-3-(3,4- dichlorophenyl)piperidin-3-yl]prop-1-yl]-4-phenylpiperidin-4 -yl]-n-methylacetamide (osanetant) et procede pour la preparation dudit compose
PCT/FR1999/001914 WO2000007987A1 (fr) 1998-08-05 1999-08-03 Formes cristallines du osanetant

Publications (1)

Publication Number Publication Date
DK1102747T3 true DK1102747T3 (da) 2003-09-29

Family

ID=9529458

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99936672T DK1102747T3 (da) 1998-08-05 1999-08-03 Krystalformer af osenetant

Country Status (32)

Country Link
US (1) US7041679B2 (da)
EP (1) EP1102747B1 (da)
JP (1) JP3807938B2 (da)
KR (1) KR100571944B1 (da)
CN (1) CN1114592C (da)
AR (1) AR019953A1 (da)
AT (1) ATE243197T1 (da)
AU (1) AU748177B2 (da)
BR (1) BR9913357A (da)
CA (1) CA2339007A1 (da)
CO (1) CO5070576A1 (da)
DE (1) DE69908951T2 (da)
DK (1) DK1102747T3 (da)
DZ (1) DZ3074A1 (da)
EA (1) EA003205B1 (da)
EE (1) EE04274B1 (da)
ES (1) ES2200535T3 (da)
FR (1) FR2782082B3 (da)
HK (1) HK1035535A1 (da)
HU (1) HUP0103134A3 (da)
IS (1) IS5821A (da)
MY (1) MY121447A (da)
NO (1) NO320645B1 (da)
NZ (1) NZ509561A (da)
PL (1) PL345999A1 (da)
PT (1) PT1102747E (da)
SK (1) SK1742001A3 (da)
TR (1) TR200100261T2 (da)
TW (1) TW527354B (da)
UA (1) UA72890C2 (da)
WO (1) WO2000007987A1 (da)
YU (1) YU8601A (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100902D0 (sv) 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0202539D0 (sv) 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
SE0401762D0 (sv) * 2004-07-05 2004-07-05 Astrazeneca Ab Novel compounds
US7648992B2 (en) * 2004-07-05 2010-01-19 Astrazeneca Ab Hydantoin derivatives for the treatment of obstructive airway diseases
SE0403085D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Novel componds
SE0403086D0 (sv) * 2004-12-17 2004-12-17 Astrazeneca Ab Compounds
TW200800954A (en) * 2006-03-16 2008-01-01 Astrazeneca Ab Novel crystal modifications
TW200831488A (en) * 2006-11-29 2008-08-01 Astrazeneca Ab Novel compounds
WO2023278843A2 (en) * 2021-07-02 2023-01-05 Acer Therapeutics, Inc. Solid forms of osanetant

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719311B1 (fr) * 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
JPH1053576A (ja) * 1996-06-07 1998-02-24 Eisai Co Ltd 塩酸ドネペジルの多形結晶およびその製造法
WO1998005640A2 (en) * 1996-08-05 1998-02-12 Smithkline Beecham S.P.A. Process for the preparation of 3,3-disubstituted piperidines
US6040316A (en) * 1996-09-16 2000-03-21 Warner-Lambert Company 3-alkyl-3-phenyl-piperidines
FR2757543B1 (fr) * 1996-12-23 1999-04-02 Sanofi Sa Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues

Also Published As

Publication number Publication date
HUP0103134A3 (en) 2003-03-28
WO2000007987A1 (fr) 2000-02-17
ATE243197T1 (de) 2003-07-15
KR20010072220A (ko) 2001-07-31
HUP0103134A2 (en) 2002-06-29
BR9913357A (pt) 2001-05-15
AU748177B2 (en) 2002-05-30
NO20010553D0 (no) 2001-02-01
NO320645B1 (no) 2006-01-09
FR2782082B3 (fr) 2000-09-22
NO20010553L (no) 2001-04-05
DE69908951T2 (de) 2004-05-19
EA200100096A1 (ru) 2001-08-27
CA2339007A1 (en) 2000-02-17
MY121447A (en) 2006-01-28
CO5070576A1 (es) 2001-08-28
HK1035535A1 (en) 2001-11-30
YU8601A (sh) 2003-07-07
DZ3074A1 (fr) 2004-07-20
TW527354B (en) 2003-04-11
CN1314888A (zh) 2001-09-26
FR2782082A1 (fr) 2000-02-11
JP3807938B2 (ja) 2006-08-09
US7041679B2 (en) 2006-05-09
ES2200535T3 (es) 2004-03-01
NZ509561A (en) 2002-10-25
DE69908951D1 (de) 2003-07-24
CN1114592C (zh) 2003-07-16
TR200100261T2 (tr) 2001-06-21
EE200100070A (et) 2002-06-17
UA72890C2 (en) 2005-05-16
EP1102747A1 (fr) 2001-05-30
EP1102747B1 (fr) 2003-06-18
SK1742001A3 (en) 2001-11-06
EA003205B1 (ru) 2003-02-27
AU5168599A (en) 2000-02-28
AR019953A1 (es) 2002-03-27
JP2002522419A (ja) 2002-07-23
PT1102747E (pt) 2003-09-30
PL345999A1 (en) 2002-01-14
IS5821A (is) 2001-01-23
KR100571944B1 (ko) 2006-04-18
US20040044215A1 (en) 2004-03-04
EE04274B1 (et) 2004-04-15

Similar Documents

Publication Publication Date Title
DK1445259T3 (da) Anvendelse af krystalformer for 2-methyl-thieno-benzodiazepin
DK1064298T3 (da) Inhibitorer af caspaser
ID27092A (id) Pembuatan ftalat anhidrida
DK1390377T3 (da) Ny krystalform af azithromycin
DK1107980T3 (da) Krystallinske former af EtO2C-CH2-(R)Cgl-Aze-Pab-OH
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
DE69912750D1 (de) Lcd-projektor
ID26514A (id) Sumur penjernih
DK0903345T3 (da) Krystalform af N-(4-trifluormethylphenyl)-5-methyl-isoxazol-4-carboxamid
DE69913236D1 (de) Brillenbügel
DK1102747T3 (da) Krystalformer af osenetant
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
DK1155050T3 (da) Fremstilling af polyolefin
NO20010782D0 (no) Krystalloscillator
FR2777096B3 (fr) Horloge
DE69823908D1 (de) Einkristallziehvorrichtung
DK1088010T3 (da) Fremstilling af polyolefiner
DE69920662D1 (de) Sibe-kristall
IS5426A (is) Fjölbrigðaform af dófetilíði
DE29809479U1 (de) Ausweisuhr
DK0927163T3 (da) Fremstilling af 1-butyl-4-piperidinylmethylamin
ID27596A (id) Bentuk paroksetina kristal
DE69901578T2 (de) Ferrielektrische Flüssigkristallverbindung
ATA144798A (de) Lünette
DE29805450U1 (de) Uhrengehäuse